𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and safety of advanced renal cell carcinoma patients treated with sorafenib: roles of cytokine pretreatment

✍ Scribed by Suzuki, Hisanori; Suzuki, Toshiro; Ishizuka, Osamu; Nishizawa, Osamu; Ueno, Manabu

Book ID
125352793
Publisher
Springer
Year
2013
Tongue
English
Weight
465 KB
Volume
19
Category
Article
ISSN
1341-9625

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Safety and efficacy results of the advan
Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America
✍ Walter M. Stadler; Robert A. Figlin; David F. McDermott; Janice P. Dutcher; Jenn πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 222 KB

## Abstract ## BACKGROUND: The Advanced Renal Cell Carcinoma Sorafenib (ARCCS) program made sorafenib available to patients with advanced renal cell carcinoma (RCC) before regulatory approval. ## METHODS: In this nonrandomized, open‐label expanded access program, 2504 patients from the United St